-+ 0.00%
-+ 0.00%
-+ 0.00%
Banco de Sabadell Climbed While Profit Fell
Share
Listen to the news

If you only glanced at Banco de Sabadell’s headlines over the past year, the picture looked mixed, with analysts split between digital upside and demographic drag, even as quarterly revenue and profit both edged lower while net margin improved. For Banco de Sabadell shareholders, the return over the past year was 26.1%, including dividends. If you had been weighing those conflicting narratives back in November 2025, what exactly were you being paid to believe about this bank’s future?

A Narrative on Simply Wall St is one investor's written case for a company, with its growth, margin and multiple assumptions spelled out. Those assumptions imply an estimated Fair Value.

The easy part of this move is behind Banco de Sabadell. Zero in on 197 high quality undervalued stocks for companies trading below our estimates.

The Two Banco de Sabadell Stories Investors Were Pricing

The shares cost €3.29 at the start of the period. Anyone looking at Banco de Sabadell then faced two very different but plausible stories about what that tag implied.

On the bullish side, the Narrative argued for a Fair Value of €4. It rested on expectations that deeper digitalization and cost discipline would cut the cost/income ratio over time, while revenue was assumed to decline 4.6% a year and profit margins to ease from 31.8% to 30.5% by 2028.

The bearish Narrative pointed to legacy IT and aging demographics, tying these to a Fair Value of €2.3. It assumed revenue would fall 5.6% annually and margins would compress from 31.8% to 30.0%, with Sabadell more exposed to slow loan demand and higher ongoing compliance costs.

BME:SAB 1-Year Stock Price Chart
BME:SAB 1-Year Stock Price Chart

What The Evidence Did To The Banco de Sabadell Argument

The clearest new fact was Q3 2026 results, where Banco de Sabadell’s revenue and net income both fell year on year while net margin rose to 34.4%. That mix challenged the bullish revenue assumptions yet kept the profitability story alive. News on AI restructuring and euro stablecoin participation pointed toward digital progress, so the evidence cut both ways.

The lesson is simple. When a bank pitch leans on efficiency, check whether net margin and cost actions move in the same direction as the story, even if revenue drifts.

What Today’s Banco de Sabadell Price Already Assumes

Banco de Sabadell now trades at €3.58, with the selected Narrative’s Fair Value sitting below that level, so its author sees less of a valuation cushion than a year ago.

The Narrative points to pressure from rapid fintech competition, tighter rules and legacy systems. A buyer today is effectively assuming those headwinds stay manageable. The question is how that squares with the Narrative’s concern about structurally higher costs and squeezed economics.

"Despite the current acceleration in loan volumes and strong asset quality metrics, Banco de Sabadell faces a growing threat from accelerated digital disruption by fintech startups and global tech companies, which is likely to erode traditional banking market share over the coming years, ultimately placing downward pressure on future revenues and compressing fee income as more customers migrate to agile, technology-led competitors."

Not everyone reads the same price the same way. → See the lower figure this Narrative lands on, and how it gets there

Which Company Could Surprise You Next?

You may be late to this rally, but that does not have to mean arriving late to every opportunity. Start with companies whose prices leave room for a different view of their future. Here are three trading below our estimates.

  • Company 1 - 38% below our estimate - targets long-life precious metal deposits while managing elevated operating and jurisdictional risks.
  • Company 2 - 32% below our estimate - adds specialty boutiques and scales digital channels to strengthen high-value customer relationships.
  • Company 3 - 20% below our estimate - expands antibiotic-eluting bone graft usage as hospitals apply it across more infection procedures.

Those are three of them. See the full list of 195 financially solid companies →

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending